Sungcalang, Gloria T.

HRN: 27-79-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2025
CEFTRIAXONE 1G (VIAL)
09/13/2025
09/20/2025
IVTT
2g
Od
Infected Breast Mass
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines